Friedenthal Financial Purchases New Holdings in Ventas, Inc. $VTR

Friedenthal Financial purchased a new stake in shares of Ventas, Inc. (NYSE:VTR) during the 1st quarter, Holdings Channel.com reports. The fund purchased 11,847 shares of the real estate investment trust’s stock, valued at approximately $969,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GoalVest Advisory LLC purchased a new position in shares of Ventas during the fourth quarter valued at approximately $26,000. Wiser Advisor Group LLC bought a new position in shares of Ventas during the third quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas in the fourth quarter worth approximately $30,000. Elyxium Wealth LLC purchased a new stake in shares of Ventas in the fourth quarter worth approximately $33,000. Finally, Reflection Asset Management bought a new stake in shares of Ventas during the 4th quarter worth approximately $34,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Stock Performance

Ventas stock opened at $86.72 on Thursday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The company has a market capitalization of $42.16 billion, a PE ratio of 157.67, a P/E/G ratio of 1.83 and a beta of 0.71. The company has a 50 day moving average price of $85.08 and a 200-day moving average price of $82.69. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period last year, the company earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is currently 378.18%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. Royal Bank Of Canada increased their target price on Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Jefferies Financial Group lifted their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Evercore reissued an “outperform” rating and set a $95.00 target price on shares of Ventas in a research note on Wednesday, April 29th. Finally, Scotiabank cut their price target on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $96.00.

Insiders Place Their Bets

In related news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.53% of the stock is currently owned by corporate insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.